Sign In
Buy SWAV
$334.75
+0 (+0%)
At Close: Aug 29, 2024
3 Healthcare Stocks That Are Beating the Market
09:29am, Sunday, 28'th Aug 2022
Here's why our roundtable is bullish on Shockwave Medical, Axsome Therapeutics, and Rhythm Pharmaceuticals.
Shockwave Medical to Participate in Two Upcoming Investor Conferences
08:30am, Friday, 26'th Aug 2022
SANTA CLARA, Calif., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascula
Can ShockWave Medical Stock Climb Higher?
05:41am, Monday, 22'nd Aug 2022
Shares of this innovative healthcare stock are up by two-thirds this year. Investors want to know if there's more fuel in the tank.
Here's Why Shockwave Medical (SWAV) is a Great Momentum Stock to Buy
01:32pm, Monday, 15'th Aug 2022
Does Shockwave Medical (SWAV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Can Shockwave Medical (SWAV) Run Higher on Rising Earnings Estimates?
01:33pm, Thursday, 11'th Aug 2022
Shockwave Medical (SWAV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why ShockWave Medical Stock Is Soaring Today
12:38pm, Tuesday, 09'th Aug 2022
Investors loved the company's Q2 update.
ShockWave Medical, Inc. (SWAV) CEO Doug Godshall on Q2 2022 Results - Earnings Call Transcript
10:02pm, Monday, 08'th Aug 2022
ShockWave Medical, Inc. (NASDAQ:SWAV ) Q2 2022 Results Conference Call August 8, 2022 4:30 PM ET Company Participants Debbie Kaster - VP, IR Doug Godshall - President, CEO Isaac Zacharias - President,
Shockwave Medical (SWAV) Q2 Earnings and Revenues Beat Estimates
07:34pm, Monday, 08'th Aug 2022
Shockwave Medical (SWAV) delivered earnings and revenue surprises of 58.14% and 12.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Shockwave Medical (SWAV) Reports Next Week: Wall Street Expects Earnings Growth
11:37am, Monday, 01'st Aug 2022
Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Fast-Growing Stocks to Buy Now
09:00am, Sunday, 31'st Jul 2022
ShockWave, Vir, and BioCryst are all seeing skyrocketing sales this quarter.
ShockWave Medical: A Hidden Gem In The Medical Device Sector
02:11pm, Tuesday, 26'th Jul 2022
ShockWave's disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical's business model lo
SANTA CLARA, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular
ShockWave Medical: Robust Growth But Overvalued
12:33pm, Monday, 18'th Jul 2022
SWAV's approval to distribute products in China to significantly boost revenue growth in the coming quarters. SWAV posted strong Q1 2022 results with a solid FY22 outlook.
Here's Why You Should Buy ShockWave Medical (SWAV) Stock
11:38am, Tuesday, 05'th Jul 2022
ShockWave Medical (SWAV) continues to benefit from solid R&D efforts and commitment to clinical studies.
Is the Options Market Predicting a Spike in Shockwave Medical (SWAV) Stock?
10:00am, Wednesday, 15'th Jun 2022
Investors need to pay close attention to Shockwave Medical (SWAV) stock based on the movements in the options market lately.
